AWS AI Backend Developed by Avahi Enables WittGen Biotechnology to Help Fight Cancer
AWS Partner Network Blog
This article discusses how Avahi Technologies, an AWS Specialization Partner, helped WittGen Biotechnology develop an AI-powered cloud platform for cancer research and treatment.
Specifically, the article covers:
- WittGen's need for a scalable cloud backend to support their AI platform for analyzing tumor DNA and genomic data
- Avahi's solution architecture using AWS services like S3, EC2, Batch, DynamoDB, CloudWatch, Cognito, and IAM
- How the platform enables researchers and clinicians to upload patient data, run AI analysis, and access results
- Avahi's expertise in designing the AWS infrastructure and coding the AI backend, accelerating WittGen's time to market
- Key benefits including scalability, reliability, security, and compliance with healthcare regulations
- Conclusion highlighting Avahi's partnership and support for WittGen's success
The AWS News Feed is currently looking for gold sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.
Related articles
Oct 2
2024
2024
AWS commits $10M to support new Cancer AI Alliance with the Fred Hutch Cancer Center
Oct 31
2024
2024
Transforming Breast Cancer Care with AWS Technology and Innovations
May 19
2025
2025
Accelerating Life Sciences Innovation with Agentic AI on AWS
Nov 19
2024
2024
Improving patient pre-screening for clinical trials with generative AI on AWS
The AWS News Feed is currently looking for silver sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.